Mulhouse, France

Fabrice Gouilleux

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabrice Gouilleux. Retrieved from https://idiyas.com/inventor/fabrice-gouilleux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabrice Gouilleux, Inventor in Mulhouse, France.

Introduction

Fabrice Gouilleux is an inventor associated with Mulhouse, France, and Ciba-Geigy Corporation. His patent work concerns MGF, a cytokine-regulated transcription factor, and its potential uses in biological research.

Latest Patents

The available information lists one patent for Gouilleux: “Cytokine Regulated Transcription Factor.” The invention describes isolated nucleic acids encoding MGF and recombinant proteins produced from them. The nucleic acids may support recombinant MGF production and serve as probes. The patent also describes transfected host cells, particularly eukaryotic cells, that contain and express these nucleic acids. In addition, it outlines methods for using MGF proteins to identify and characterize compounds that affect intracellular signal transduction by a lactogenic hormone. The listed portfolio comprises 1 patent.

Career Highlights

Gouilleux’s documented patent activity connects molecular biology with the study of hormone-related cellular signaling. His work at Ciba-Geigy Corporation is associated with research applications involving MGF, recombinant proteins, and transfected cells.

Collaborations

Bernd Groner and Hiroshi Wakao are identified as Gouilleux’s coworkers. Their names provide context for the research environment associated with his patent work.

Conclusion

Fabrice Gouilleux’s listed invention focuses on MGF-encoding nucleic acids, recombinant proteins, and tools for investigating lactogenic hormone signaling.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…